Geron Corporation (NASDAQ:GERN) Q4 2024 Earnings Conference Call February 26, 2025 8:00 AM ET
Company Participants
Aron Feingold – VP of IR and Corporate Communications
John Scarlett – Chairman and CEO
Michelle Robertson – EVP and CFO
Jim Ziegler – EVP and CCO
Joseph Eid – EVP, R&D
Faye Feller – EVP and CMO
Conference Call Participants
Peter Lawson – Barclays
Tara Bancroft – TD Cowen
Faisal Khurshid – Leerink Partners
Greg Harrison – Scotiabank
Stephen Willey – Stifel
Emily Bodnar – H.C. Wainwright
Kalpit Patel – B. Riley Securities
Gil Blum – Needham
Operator
Hello, and welcome to the Geron Fourth Quarter and Full Year 2024 Earnings Call. [Operator Instructions]
I would now like to turn the conference over to Aron Feingold, Vice President of Investor Relations and Corporate Communications. You may begin.
Aron Feingold
Good morning, everyone. Welcome to the Geron Corporation fourth quarter and full year 2024 earnings conference call. I am Aron Feingold, Geron’s Vice President of Investor Relations and Corporate Communications. I’m joined today by several members of Geron’s management team, Dr. John Scarlett, Chairman and Chief Executive Officer; Michelle Robertson, Executive Vice President and Chief Financial Officer; Jim Ziegler, Executive Vice President and Chief Commercial Officer; Dr. Joseph Eid, Executive Vice President, Research and Development; and Dr. Faye Feller, Executive Vice President and Chief Medical Officer.
Before we begin, please note that during the course of this presentation and question-and-answer session, we will be making forward-looking statements regarding future events, performance, plans, expectations and other projections including those relating to the launch commercial opportunity and therapeutic potential of RYTELO, anticipated clinical and commercial events and related timelines, the sufficiency of Geron’s financial resources and other statements that are not historical facts. Actual events or results could differ materially.
Therefore, I refer you to the discussion
Read the full article here